141 related articles for article (PubMed ID: 29353110)
1. Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.
Kriegsmann K; Schmitt A; Kriegsmann M; Bruckner T; Anyanwu A; Witzens-Harig M; Müller-Tidow C; Klein S; Wuchter P
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1281-1288. PubMed ID: 29353110
[TBL] [Abstract][Full Text] [Related]
2. Mobilization and Collection of Peripheral Blood Stem Cells in Adults: Focus on Timing and Benchmarking.
Kriegsmann K; Wuchter P
Methods Mol Biol; 2019; 2017():41-58. PubMed ID: 31197767
[TBL] [Abstract][Full Text] [Related]
3. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
Lefrere F; Makke J; Fermand J; Marolleau J; Dal Cortivo L; Alberti C; Mouton V; Benbunan M; Miclea J
Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
[TBL] [Abstract][Full Text] [Related]
4. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
6. Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
Lisenko K; Baertsch MA; Meiser R; Pavel P; Bruckner T; Kriegsmann M; Schmitt A; Witzens-Harig M; Ho AD; Hillengass J; Wuchter P
Transfusion; 2017 Oct; 57(10):2359-2365. PubMed ID: 28653421
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.
Lisenko K; Wuchter P; Hansberg M; Mangatter A; Benner A; Ho AD; Goldschmidt H; Hegenbart U; Schönland S
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1870-1878. PubMed ID: 28754546
[TBL] [Abstract][Full Text] [Related]
8. Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma.
Lisenko K; Cremer M; Schwarzbich MA; Kriegsmann M; Ho AD; Witzens-Harig M; Wuchter P
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1397-1402. PubMed ID: 27060439
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
10. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
[TBL] [Abstract][Full Text] [Related]
12. Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Blank N; Lisenko K; Pavel P; Bruckner T; Ho AD; Wuchter P
Eur J Haematol; 2016 Jul; 97(1):78-82. PubMed ID: 26381040
[TBL] [Abstract][Full Text] [Related]
13. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
Duong HK; Bolwell BJ; Rybicki L; Koo A; Hsi ED; Figueroa P; Dean R; Pohlman B; Kalaycio M; Andresen S; Sobecks R; Copelan E
J Clin Apher; 2011; 26(3):111-5. PubMed ID: 21647951
[TBL] [Abstract][Full Text] [Related]
14. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
[TBL] [Abstract][Full Text] [Related]
15. Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.
Kriegsmann K; Heilig C; Cremer M; Novotny P; Kriegsmann M; Bruckner T; Müller-Tidow C; Egerer G; Wuchter P
Eur J Haematol; 2017 Nov; 99(5):459-464. PubMed ID: 28884875
[TBL] [Abstract][Full Text] [Related]
16. PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U
Hematol Oncol; 2015 Sep; 33(3):125-32. PubMed ID: 24890497
[TBL] [Abstract][Full Text] [Related]
17. The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed.
D'Hondt L; Emmons RV; André M; Guillaume T; Feyens AM; Canon JL; Humblet Y; Longueville J; Symann M
Leuk Lymphoma; 1999 Jun; 34(1-2):105-9. PubMed ID: 10350337
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of mobilization regimes of blood hemopoietic stem cells in patients with multiple myeloma].
Pokrovskaia OS; Mendeleeva LP; Urnova ES; Gaponova TV; Gribanova EO; Alekseeva IV; Drokov MIu; Kalinin NN; Gretsov EM; Kliasova GA; Savchenko VG
Ter Arkh; 2011; 83(7):50-7. PubMed ID: 21894752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
